Literature DB >> 19505857

Analysis of endocannabinoids, their congeners and COX-2 metabolites.

Philip J Kingsley1, Lawrence J Marnett.   

Abstract

Since the discovery of the endocannabinoids anandamide and 2-arachidonoylglycerol (2-AG) in the early 1990s, the endocannabinoid system has been implicated in a wide array of physiological processes, such as control of food intake and energy balance, fertility and obesity. As the importance of this system becomes apparent, there is a tremendous need for robust, sensitive and efficient analytical methodology for the examination of the endocannabinoids, their congeners and putative metabolites. This review will summarize quantitative analytical methodology as reported in the literature from 1992 to present for the analysis of endocannabinoids and related compounds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19505857      PMCID: PMC4903075          DOI: 10.1016/j.jchromb.2009.05.024

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  56 in total

1.  Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo.

Authors:  K R Kozak; B C Crews; J L Ray; H H Tai; J D Morrow; L J Marnett
Journal:  J Biol Chem       Date:  2001-07-10       Impact factor: 5.157

2.  Discovery metabolite profiling--forging functional connections between the proteome and metabolome.

Authors:  Alan Saghatelian; Benjamin F Cravatt
Journal:  Life Sci       Date:  2005-08-19       Impact factor: 5.037

3.  Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues.

Authors:  Filomena Fezza; Tiziana Bisogno; Alberto Minassi; Giovanni Appendino; Raphael Mechoulam; Vincenzo Di Marzo
Journal:  FEBS Lett       Date:  2002-02-27       Impact factor: 4.124

4.  Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.

Authors:  Amy C Porter; John-Michael Sauer; Michael D Knierman; Gerald W Becker; Michael J Berna; Jingqi Bao; George G Nomikos; Petra Carter; Frank P Bymaster; Andrea Baker Leese; Christian C Felder
Journal:  J Pharmacol Exp Ther       Date:  2002-06       Impact factor: 4.030

5.  Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue.

Authors:  K Kempe; F F Hsu; A Bohrer; J Turk
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

Review 6.  2-Arachidonoyl-glycerol as an "endocannabinoid": limelight for a formerly neglected metabolite.

Authors:  V Di Marzo
Journal:  Biochemistry (Mosc)       Date:  1998-01       Impact factor: 2.487

7.  Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.

Authors:  Tim C Kirkham; Claire M Williams; Filomena Fezza; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

8.  Analysis of endocannabinoids by Ag+ coordination tandem mass spectrometry.

Authors:  Philip J Kingsley; Lawrence J Marnett
Journal:  Anal Biochem       Date:  2003-03-01       Impact factor: 3.365

9.  An improved LC-MS/MS procedure for brain prostanoid analysis using brain fixation with head-focused microwave irradiation and liquid-liquid extraction.

Authors:  Mikhail Y Golovko; Eric J Murphy
Journal:  J Lipid Res       Date:  2008-01-09       Impact factor: 5.922

10.  Endocannabinoid signalling in the blood of patients with schizophrenia.

Authors:  Nicola De Marchi; Luciano De Petrocellis; Pierangelo Orlando; Fabiana Daniele; Filomena Fezza; Vincenzo Di Marzo
Journal:  Lipids Health Dis       Date:  2003-08-19       Impact factor: 3.876

View more
  11 in total

Review 1.  Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses.

Authors:  Xianlin Han; Kui Yang; Richard W Gross
Journal:  Mass Spectrom Rev       Date:  2011-07-13       Impact factor: 10.946

2.  Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea.

Authors:  Paula Urquhart; Jenny Wang; David F Woodward; Anna Nicolaou
Journal:  J Lipid Res       Date:  2015-05-31       Impact factor: 5.922

Review 3.  Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.

Authors:  Matthew W Buczynski; Loren H Parsons
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

4.  Lipidomic metabolism analysis of the endogenous cannabinoid anandamide (N-arachidonylethanolamide).

Authors:  Ekaterina A Placzek; Bruce R Cooper; Andrew T Placzek; Julia A Chester; V Jo Davisson; Eric L Barker
Journal:  J Pharm Biomed Anal       Date:  2010-04-01       Impact factor: 3.935

5.  Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma.

Authors:  Jodianne T Wood; John S Williams; Lakshmipathi Pandarinathan; David R Janero; Carol J Lammi-Keefe; Alexandros Makriyannis
Journal:  J Lipid Res       Date:  2010-01-13       Impact factor: 5.922

Review 6.  Selection of internal standards for accurate quantification of complex lipid species in biological extracts by electrospray ionization mass spectrometry-What, how and why?

Authors:  Miao Wang; Chunyan Wang; Xianlin Han
Journal:  Mass Spectrom Rev       Date:  2016-01-15       Impact factor: 10.946

7.  Brain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation.

Authors:  Stephen A Brose; Svetlana A Golovko; Mikhail Y Golovko
Journal:  Lipids       Date:  2016-03-28       Impact factor: 1.880

Review 8.  Druggable Targets in Endocannabinoid Signaling.

Authors:  Ann M Gregus; Matthew W Buczynski
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

9.  Accurate quantification of lipid species by electrospray ionization mass spectrometry - Meet a key challenge in lipidomics.

Authors:  Kui Yang; Xianlin Han
Journal:  Metabolites       Date:  2011-11-11

10.  High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate.

Authors:  Xunliang Tong; Hui Peng; Donghui Liu; Liang Ji; Chenguang Niu; Jun Ren; Bing Pan; Jianying Hu; Lemin Zheng; Yining Huang
Journal:  Cardiovasc Diabetol       Date:  2013-01-30       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.